Use of magnetic resonance spectroscopy to calibrate and select doses, formulations, and devices for intra-nasal administration of n-acetylcysteine
AU2026213971A1Pending Publication Date: 2026-08-20NEURONASAL INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- AU2026213971
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-08-04
- Publication Date
- 2026-08-20
Smart Images

Figure 00000073_0000 
Figure 00000074_0000 
Figure 00000075_0000
Abstract
via intranasal administration. The effect of intranasal NAC administration can be monitored intranasal NAC administration to treat a condition. -1- 20 26 21 39 71 04 A ug 2 02 6 U S E O F M A G N E T I C R E S O N A N C E S P E C T R O S C O P Y T O C A L I B R A T E A N D A D M I N I S T R A T I O N O F N - A C E T Y L C Y S T E I N E 2 0 2 6 2 1 3 9 7 1 0 4 2 0 2 6 A u g A B S T R A C T
Need to check novelty before this filing date? Find Prior Art